The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes

被引:106
作者
Song, Jianxun
Salek-Ardakani, Shahram
So, Takanori
Croft, Michael [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, Div Mol Immunol, La Jolla, CA 92037 USA
[2] Third Mil Med Univ, Inst Immunol PLA, Chongqing, Peoples R China
关键词
D O I
10.1038/ni1413
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28-deficient T cells arrest at the G1-S transition of the cell cycle. Here we show that this is controlled by the kinase aurora B, which exists in a complex with survivin and mammalian target of rapamycin ( mTOR). Expression of aurora B in Cd28(-/-) T cells augmented phosphorylation of mTOR substrates, expression of cyclin A, hyperphosphorylation of retinoblastoma protein and activation of cyclin-dependent kinases 1 and 2 and promoted cell cycle progression. Interleukin 2 enhanced aurora B activity, and inactive aurora B prevented interleukin 2-induced proliferation. Moreover, expression of aurora B restored Cd28(-/-) T cell proliferation and promoted inflammation in vivo. These data identify aurora B, along with survivin and mTOR, as a regulator of the G1-S checkpoint in T cells.
引用
收藏
页码:64 / 73
页数:10
相关论文
共 50 条
  • [31] INTERLEUKIN-2-MEDIATED ELIMINATION OF THE P27(KIP1) CYCLIN-DEPENDENT KINASE INHIBITOR PREVENTED BY RAPAMYCIN
    NOURSE, J
    FIRPO, E
    FLANAGAN, WM
    COATS, S
    POLYAK, K
    LEE, MH
    MASSAGUE, J
    CRABTREE, GR
    ROBERTS, JM
    [J]. NATURE, 1994, 372 (6506) : 570 - 573
  • [32] Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
    O'Connor, DS
    Grossman, D
    Plescia, J
    Li, FZ
    Zhang, H
    Villa, A
    Tognin, S
    Marchisio, PC
    Altieri, DC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) : 13103 - 13107
  • [33] Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death
    Okada, H
    Bakal, C
    Shahinian, A
    Elia, A
    Wakeham, A
    Suh, WK
    Duncan, GS
    Ciofani, M
    Rottapel, R
    Zúñiga-Pflücker, JC
    Mak, TW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (03) : 399 - 410
  • [34] Powell JD, 1999, J IMMUNOL, V162, P2775
  • [35] Powell JD, 2001, EUR J IMMUNOL, V31, P3737, DOI 10.1002/1521-4141(200112)31:12<3737::AID-IMMU3737>3.0.CO
  • [36] 2-G
  • [37] T-CELL ANTIGEN CD28 INTERACTS WITH THE LIPID KINASE PHOSPHATIDYLINOSITOL 3-KINASE BY A CYTOPLASMIC TYR(P)-MET-XAA-MET MOTIF
    PRASAD, KVS
    CAI, YC
    RAAB, M
    DUCKWORTH, B
    CANTLEY, L
    SHOELSON, SE
    RUDD, CE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2834 - 2838
  • [38] OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation
    Salek-Ardakani, S
    Song, JX
    Halteman, BS
    Jember, AGH
    Akiba, H
    Yagita, H
    Croft, M
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (02) : 315 - 324
  • [39] The B7-CD28 superfamily
    Sharpe, AH
    Freeman, GJ
    [J]. NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) : 116 - 126
  • [40] Tumor necrosis factor α inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis
    Shen, WH
    Yin, YX
    Broussard, SR
    McCusker, RH
    Freund, GG
    Dantzer, R
    Kelley, KW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (09) : 7438 - 7446